Skip to content

Clinical Research on Postoperative Pain Control with Cocktail Anaesthetic Continuous Intraarticular Infusion after Total Knee Arthroplasty

Clinical Research on Postoperative Pain Control with Cocktail Anaesthetic Continuous Intraarticular Infusion after Total Knee Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003999
Enrollment
Unknown
Registered
2013-12-15
Start date
2014-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

1:cocktail anaesthetic continuous intraarticular infusion
2:patient controlled epidural analgesia

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients in department of orthopedics, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine; Meet the diagnostic criteria for knee osteoarthritis; 2. Planned spinal anesthesia; American Society of Anesthesiologists (ASA) physical status I-II; 3. Scheduled for unilateral total knee arthroplasty; 4. Patients aged 50~80 years old.

Exclusion criteria

Exclusion criteria: 1. Unwillingness of the patient; 2. Presence of neuropathic pain or sensory disorders in the leg to be operated on; 3. Intolerance to the study drugs; 4. Failure of spinal anesthesia; 5. Previous major knee surgery, re-operation or trauma to the knee within the study period.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;active range of motion;intraarticular infection markers;rescue analgesia and adverse event;

Countries

China

Contacts

Public ContactDa Guo

The Second School of Clinic Medicine, Guangzhou University of Chinese Medicine

341127403@QQ.COM+86 020 81887233 33229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026